Charles River Laboratories International (CRL) Total Current Liabilities (2009 - 2025)

Charles River Laboratories International's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $1.1 billion for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 12.7% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $1.1 billion (up 12.7% YoY), while the FY2025 annual figure was $1.1 billion, up 12.7% from the prior year.
• Total Current Liabilities was $1.1 billion for Q4 2025 at Charles River Laboratories International, roughly flat from $1.1 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.1 billion in Q3 2025 to a low of $803.4 million in Q1 2021.
• Historically, Total Current Liabilities has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
• The sharpest annual moves came in 2021 and 2024: Total Current Liabilities grew 27.7% in 2021, then fell 5.96% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $1.0 billion in 2021, then rose by 5.65% to $1.1 billion in 2022, then fell by 3.34% to $1.1 billion in 2023, then fell by 5.78% to $994.1 million in 2024, then increased by 12.7% to $1.1 billion in 2025.
• The last three Total Current Liabilities figures came in at $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025), per Business Quant data.